Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01743339 · ClinicalTrials.gov registry record · NA

Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
110
Enrollment target

NCT01743339 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 110 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01743339, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target

Study Summary

The primary purpose of this study is to test whether and how cognitive-behavioral therapy for insomnia (CBTi), a well-supported and highly effective insomnia treatment, may directly improve Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) symptoms. The study is designed as a randomized controlled trial (RCT) to test the effect of CBTi on symptoms of PTSD and co-morbid depression prior to an evidence-based PTSD intervention and to assess the role of neurobiological processes and sleep architecture in mediating treatment outcomes.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2013-01
Est. Completion 2017-02
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT01743339

The ClinicalTrials.gov registry entry for NCT01743339 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01743339 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01743339 about?

NCT01743339 is a clinical study titled "Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress". The primary purpose of this study is to test whether and how cognitive-behavioral therapy for insomnia (CBTi), a well-supported and highly effective insomnia treatment, may directly improve Posttraumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) symptoms. The study is designed as a ...

What is the current status of trial NCT01743339?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-01. Estimated completion is 2017-02.

What interventions are being tested in trial NCT01743339?

The interventions under investigation include: Control (BEHAVIORAL), Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01743339?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.